Rapt Therapeutics saw an upward trend in its earnings estimates on July 16, 2025, leading to a Zacks Rank #1 rating.
1 report, 1 independent
Updated Jul 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rapt Therapeutics saw an upward trend in its earnings estimates on July 16, 2025, leading to a Zacks Rank #1 rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Rapt Therapeutics (United States)
company in South San Francisco, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksRapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why Investors might want to bet on Rapt Therapeutics (RAPT), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade pri